Sign in Subscribe
Epidemiology

Elevated Liver Enzymes Linked to Increased Risk of Diabetic Nephropathy in Type 2 Diabetes Patients

Strategic Insights

— 1 min read

Research conducted by a team of scientists at Guilan University of Medical Sciences has revealed a significant association between increased serum levels of liver enzymes and the risk of diabetic microvascular complications among patients with type 2 diabetes. The study, which included 403 patients from the Prospective Epidemiological Research Studies in IRAN (PERSIAN) Guilan Cohort Study (PGCS), found that elevated levels of gamma-glutamyl transferase (GGT) were significantly associated with the development of diabetic nephropathy.

Key Takeaways:

  • The study included 403 patients with type 2 diabetes from the PGCS, who underwent demographic, anthropometric, and clinical assessments to evaluate the association between liver enzymes and diabetic microvascular complications.
  • Urine analysis, blood laboratory tests, and fundus photometry were used to assess diabetic nephropathy and serum liver enzyme levels.
  • The study found that increased levels of GGT (OR = 3.42, 95% CI, 1.28-6.00, p = 0.014) were significantly associated with the development of diabetic nephropathy, while no association was observed between ASAT, ALT, or ALP and diabetic nephropathy.
  • The results suggested that increased levels of GGT are an independent risk factor for the development of nephropathy in patients with type 2 diabetes.
  • The study highlights the importance of monitoring liver enzyme levels in patients with type 2 diabetes to prevent and manage diabetic microvascular complications.
  • The research was conducted by a team of scientists led by Zahra Abbasi Ranjbar, Department of Internal Medicine, School of Medicine, Guilan University of Medical Sciences, Rasht, Iran.

Statistics:

  • 403 patients with type 2 diabetes were included in the study from the PERSIAN Guilan Cohort Study (PGCS).
  • Elevated GGT levels were associated with a 3.42-fold increased risk of diabetic nephropathy (95% CI, 1.28-6.00, p = 0.014).
  • The study used SPSS version 16.0 for statistical analysis, with a significant level of p < 0.05.

Sources:

  • Association between Elevated Liver Enzymes and Microvascular Complications in Patients with Type 2 Diabetes: The PERSIAN Guilan Cohort Study. Clinical Diabetology, 2024, 13(5).
  • Clinical Diabetology - https://journals.viamedica.pl/diabetologia_kliniczna/index
  • Via Medica, the publisher of Clinical Diabetology.

Read more